Determination of doxorubicin and its metabolites in rat serum and bile by LC: application to preclinical pharmacokinetic studies
- 8 October 2002
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 30 (4) , 1063-1074
- https://doi.org/10.1016/s0731-7085(02)00442-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Anthracycline-induced cardiomyopathySeminars in Oncology, 2001
- Effects of doxorubicinol on excitation–contraction coupling in guinea pig ventricular myocytesEuropean Journal of Pharmacology, 2001
- Doxorubicin Metabolism and Toxicity in Human Myocardium: Role of Cytoplasmic Deglycosidation and Carbonyl ReductionChemical Research in Toxicology, 2000
- Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Adriamycin cardiomyopathy: pathophysiology and preventionThe FASEB Journal, 1997
- Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.Journal of Clinical Investigation, 1995
- A Sensitive and Simple High-Performance Liquid Chromatographic Method for the Determination of Doxorubicin and Its Metabolites in PlasmaTherapeutic Drug Monitoring, 1993
- Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1992
- HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patientsJournal of Pharmaceutical and Biomedical Analysis, 1991
- Early and delayed clinical cardiotoxicity of doxorubicinCancer, 1985